Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-17 | FENNEC PHARMACEUTICALS INC. | Haigh Adrian
(CHIEF OPERATING OFFICER) |
S | Common Shares | A | 88888 | $2.31 - $9.91 | $536,659 |
| 2024-04-15 | FENNEC PHARMACEUTICALS INC. | Haigh Adrian
(CHIEF OPERATING OFFICER) |
S | Common Shares | A | 88888 | $2.31 - $10.30 | $559,845 |
| 2024-04-15 | FENNEC PHARMACEUTICALS INC. | RALLIS CHRIS A
(Director) |
S | Common Shares | D | 800 | $10.45 - $10.45 | $8,360 |
| 2024-04-15 | FENNEC PHARMACEUTICALS INC. | RALLIS CHRIS A
(Director) |
M | Common Shares | A | 1389 | $10.45 - $10.45 | $14,515 |
| 2024-04-04 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
S | Common shares | D | 88583 | $10.75 - $10.89 | $958,668 |
| 2024-04-03 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
S | Common shares | D | 40584 | $10.78 - $10.78 | $437,450 |
| 2024-04-01 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
P | Common shares | A | 29167 | $0.00 - $0.00 | $0 |
| 2024-03-25 | FENNEC PHARMACEUTICALS INC. | Andrade Robert
(CHIEF FINANCIAL OFFICER) |
S | Common shares | D | 13975 | $11.00 - $11.00 | $153,690 |
| 2023-11-20 | FENNEC PHARMACEUTICALS INC. | RALLIS CHRIS A
(Director) |
S | Common Shares | D | 269 | $8.25 - $8.25 | $2,219 |
| 2023-11-03 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
M | Common shares | A | 74793 | $1.59 - $1.59 | $118,920 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |